Cryotherapy in the Treatment of Desmoid Tumors

ConditionDesmoid
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIstituto Ortopedico Rizzoli

About this trial

Desmoid tumor is a benign neoplasm with an unpredictable course and a high rate of local recurrence if treated surgically. Therefore, over time the surgical approach has become conservative, preferring simple observation or medical therapy in case of disease progression through the use of hormonal therapy and low-dose chemotherapy. Since this neoplasm remains benign, our study aims to avoid chemotherapy in patients usually young through the use of a minimally invasive treatment such as cryotherapy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

histologic diagnosis of desmoid tumors

age > 18 years

abdominal and extra-abdominal desmoid tumors

Disqualifiers

contraindication to the procedure by the interventional radiologist in terms of tumor proximity to neurologic/vascular structures

retroperitoneal desmoid tumors

age < 18 years

Trial design

Design model

Single group

Treatments tested in this trial

  • Cryotherapy

    Procedure/Surgery

    The procedure involves general or peripheral anesthesia and percutaneous treatment under CT control with probes capable of forming ice spheres of up to 3 cm that will be used in sufficient number to treat the neoplasm completely.

Treatment groups

94 Participants
are divided into 1 treatment group
Group A: PatientsExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

response to treatment

assessment of tumor response to treatment will be performed using the solid tumor response criteria

Time frame
At baseline (time 0)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.